Relationships were developed with pharmaceutical companies in an effort to curb the patent medicine crisis and consolidate the patient base around the medical doctor.
Before the biological effects of radiation were known, many physicians and corporations began marketing radioactive substances as patent medicine in the form of glow-in-the-dark pigments.
This is all in addition to the more mundane tasks of testing household goods such as cosmetics, patent medicine, and wallpaper for toxic and potentially harmful additives.
